Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 93

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 93
---
eree of such Common Shares free and clear of all Encumbrances and 
 shall be entered in the register of the Shareholders maintained by or on behalf of the Company;                 |

| (g) | each Common Share outstanding immediately prior to the Effective Time (other than a Common Share held by a                                                                                                                                         
 Dissenting Shareholder in respect of which Dissent Rights have been validly exercised under Section 2.3(f), the Purchaser or any affiliate of the Purchaser) shall be deemed to be assigned and transferred by the holder thereof to the Purchaser 
 in exchange for the issuance by the Purchaser of one CVR per Common Share, and:                                                                                                                                                                    |

| (i) | each registered holder of such Common Shares shall cease to be the registered holder thereof and to have any 
 rights as a Shareholder other than the right to be paid one CVR per Common Share;                            |

| (ii) | the name of each such registered holder shall be removed from the register of the Shareholders maintained by or 
 on behalf of the Company; and                                                                                   |

A-6

| (iii) | the Purchaser shall be deemed to be the transferee of such Common Shares free and clear of all Encumbrances and 
 shall be entered in the register of the Shareholders maintained by or on behalf of the Company; and             |

| (h) | the exchanges and cancellations provided for in this Section 2.3 will be deemed to occur on the Effective              
 Date, notwithstanding that certain of the procedures related thereto are not completed until after the Effective Date. |

ARTICLE 3 RIGHTS OF DISSENT

| 3.1 | Rights of Dissent |

Each registered holder of Common Shares as of the Record Date may exercise dissent rights with respect to all Common Shares held by such holder (“ Dissent Rights”) in connection with the Arrangement pursuant to and in the manner set forth in Chapter XIV – Division I of the QBCA, as modified by this Section 3.1, the Interim Order and any other order of the Court, provided that, as a condition precedent to the exercise of Dissent Rights and notwithstanding Section 376 of the QBCA, the written notice setting forth such a registered Shareholder’s objection to the Arrangement Resolution and exercise of Dissent Rights must be received by the Company not later than 5:00 p.m. (Montréal time) two Business Days immediately preceding the date of the Meeting (as it may be adjourned or postponed